Showing results (161-170 of 213) with videos related to

Sort By:
Pageof 22
Cancer|July 1, 1995
Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric studyT Hirose, B W Scheithauer, M B Lopes, et al.
British Journal of Cancer|May 18, 2001
The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expressionS Vonlanthen, J Heighway, H J Altermatt, et al.
International Journal of Cancer|September 9, 1993
Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: optimization of the therapeutic indexH B Ris, H J Altermatt, C M Stewart, et al.
International Journal of Cancer|December 1, 1994
Parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA alkyltransferase and P-glycoprotein as indicators of drug resistance in tumor and normal lung of patients with lung cancerA E Oberli-Schrämmli, F Joncourt, M Stadler, et al.
International Journal of Cancer|January 2, 1993
Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesotheliomaH B Ris, H J Altermatt, B Nachbur, et al.
Applied Geography (Sevenoaks, England)|December 20, 2022
COVID-19 exacerbates unequal food accessArmita Kar, Yasuyuki Motoyama, Andre L Carrel, et al.
Journal of Childhood Obesity|July 13, 2018
Salivary Cortisol Does Not Correlate with Metabolic Syndrome Markers or Subjective Stress in Overweight ChildrenRobert B Strait, Marcia J Slattery, Aaron L Carrel, et al.
The Journal of Pediatrics|October 1, 2003
Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi SyndromeM Tracy Bekx, Aaron L Carrel, Timothy C Shriver, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2010
Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndromeAaron L Carrel, Susan E Myers, Barbara Y Whitman, et al.
Lung Cancer (Amsterdam, Netherlands)|September 12, 2001
Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumoursM Gugger, A Kappeler, S Vonlanthen, et al.
Pageof 22